147 related articles for article (PubMed ID: 11561475)
1. [Strategies to reduce the progression of renal disease in patients with type II diabetes mellitus].
Burgos Calderón R
P R Health Sci J; 2001 Jun; 20(2):157-60. PubMed ID: 11561475
[TBL] [Abstract][Full Text] [Related]
2. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
[TBL] [Abstract][Full Text] [Related]
3. [The role of angiotensin II AT1-receptor antagonists in renal and cardiac protection in type-2 diabetes mellitus].
Ravera M; Deferrari L; Ratto E; Vettoretti S; Parodi D; Deferrari G
Ital Heart J Suppl; 2003 Mar; 4(3):210-6. PubMed ID: 12784755
[TBL] [Abstract][Full Text] [Related]
4. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].
Dussol B; Berland Y
Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717
[TBL] [Abstract][Full Text] [Related]
5. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
6. Effects of gender, Helicobacter pylori and hepatitis B virus serology status on cardiovascular and renal complications in Chinese type 2 diabetic patients with overt nephropathy.
Lo MK; Lee KF; Chan NN; Leung WY; Ko GT; Chan WB; So WY; Ng MC; Ho CS; Tam JS; Lam CW; Tong PC; Chan JC
Diabetes Obes Metab; 2004 May; 6(3):223-30. PubMed ID: 15056131
[TBL] [Abstract][Full Text] [Related]
7. [Guidelines for diagnosis and therapy of diabetic nephropathy].
De Ferrari G;
G Ital Nefrol; 2003; 20 Suppl 24():S96-108. PubMed ID: 14666506
[TBL] [Abstract][Full Text] [Related]
8. Effects of structured care by a pharmacist-diabetes specialist team in patients with type 2 diabetic nephropathy.
Leung WY; So WY; Tong PC; Chan NN; Chan JC
Am J Med; 2005 Dec; 118(12):1414. PubMed ID: 16378791
[TBL] [Abstract][Full Text] [Related]
9. Hypertension and renal complications in type 2 diabetes.
Nosadini R
Semin Vasc Med; 2002 Feb; 2(1):109-19. PubMed ID: 16222601
[TBL] [Abstract][Full Text] [Related]
10. [Diabetes mellitus, hypertension and kidney].
Monhart V
Vnitr Lek; 2008 May; 54(5):499-504, 507. PubMed ID: 18630636
[TBL] [Abstract][Full Text] [Related]
11. [Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy].
Parving HH; Brenner BM; Cooper ME; de Zeeuw D; Keane WF; Mitch WE; Remuzzi G; Snapinn SM; Zhang Z; Shahinfar S
Ugeskr Laeger; 2001 Oct; 163(40):5514-9. PubMed ID: 11601117
[TBL] [Abstract][Full Text] [Related]
12. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
13. Diabetic nephropathy. Prevention and early referral.
Pylypchuk G; Beaubien E
Can Fam Physician; 2000 Mar; 46():636-42. PubMed ID: 10752002
[TBL] [Abstract][Full Text] [Related]
14. [Risk factors of diabetic nephropathy progression in patients with a long history of diabetic mellitus as shown by a retrospective analysis].
Shestakova MV; Koshel' LV; Vagodin VA; Dedov II
Ter Arkh; 2006; 78(5):60-4. PubMed ID: 16889052
[TBL] [Abstract][Full Text] [Related]
15. Advances in the treatment of diabetic renal disease: focus on losartan.
Rayner B
Curr Med Res Opin; 2004 Mar; 20(3):333-40. PubMed ID: 15025842
[TBL] [Abstract][Full Text] [Related]
16. [Diabetic nephropathy in type 2 diabetes--epidemiology, early diagnosis and therapeutic strategies].
Schernthaner G
Klin Wochenschr; 1992; 69 Suppl 29():28-34. PubMed ID: 1614188
[TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study.
Remuzzi G; Macia M; Ruggenenti P
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S90-7. PubMed ID: 16565256
[TBL] [Abstract][Full Text] [Related]
18. Type II diabetic nephropathy: its clinical course and therapeutic implications.
Rodby RA
Semin Nephrol; 1997 Mar; 17(2):132-47. PubMed ID: 9148379
[TBL] [Abstract][Full Text] [Related]
19. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
de Zeeuw D
Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of renal biopsy in type-II diabetic patients.
Arif M; Arif MK; Arif MS
J Coll Physicians Surg Pak; 2009 Oct; 19(10):627-31. PubMed ID: 19811713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
